Skip to main content
. 2020 Mar 25;111(5):1685–1691. doi: 10.1111/cas.14368

FIGURE 5.

FIGURE 5

Overall survival in patients treated with chemotherapy. Red line, patients with non–small cell lung cancer (NSCLC) who received epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI); blue line, patients with NSCLC who did not receive EGFR‐TKI; dark green line, patients with small cell lung cancer